Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR
Clinical trial NCT02720185 · TERMINATED
Trial details
- NCT number
- NCT02720185
- Sponsor
- University of Wisconsin, Madison
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-03
- Primary completion
- 2020-07-02
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.